Deutsche Bank’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-53,372
| Closed | -$8.07M | – | 4127 |
|
2022
Q3 | $8.07M | Sell |
53,372
-45,560
| -46% | -$6.89M | ﹤0.01% | 1027 |
|
2022
Q2 | $14.4M | Sell |
98,932
-671,935
| -87% | -$97.9M | 0.01% | 872 |
|
2022
Q1 | $91.4M | Sell |
770,867
-27,113
| -3% | -$3.21M | 0.04% | 398 |
|
2021
Q4 | $110M | Buy |
797,980
+60,009
| +8% | +$8.27M | 0.05% | 360 |
|
2021
Q3 | $103M | Sell |
737,971
-16,323
| -2% | -$2.27M | 0.05% | 356 |
|
2021
Q2 | $73.2M | Buy |
754,294
+27,614
| +4% | +$2.68M | 0.04% | 475 |
|
2021
Q1 | $49.7M | Buy |
726,680
+609,527
| +520% | +$41.7M | 0.03% | 589 |
|
2020
Q4 | $10M | Sell |
117,153
-410,537
| -78% | -$35.2M | 0.01% | 1032 |
|
2020
Q3 | $34.3M | Sell |
527,690
-82,957
| -14% | -$5.39M | 0.02% | 556 |
|
2020
Q2 | $44.6M | Buy |
610,647
+44,314
| +8% | +$3.24M | 0.03% | 468 |
|
2020
Q1 | $19.3M | Buy |
566,333
+73,576
| +15% | +$2.5M | 0.02% | 666 |
|
2019
Q4 | $26.8M | Buy |
492,757
+399,876
| +431% | +$21.8M | 0.02% | 678 |
|
2019
Q3 | $3.87M | Sell |
92,881
-53,470
| -37% | -$2.23M | ﹤0.01% | 1526 |
|
2019
Q2 | $6.41M | Sell |
146,351
-147,244
| -50% | -$6.45M | ﹤0.01% | 1646 |
|
2019
Q1 | $15.1M | Buy |
293,595
+108,829
| +59% | +$5.6M | 0.01% | 1125 |
|
2018
Q4 | $6.83M | Sell |
184,766
-80,244
| -30% | -$2.97M | ﹤0.01% | 1542 |
|
2018
Q3 | $9.95M | Buy |
265,010
+64,725
| +32% | +$2.43M | 0.01% | 1636 |
|
2018
Q2 | $7.92M | Buy |
200,285
+138,507
| +224% | +$5.47M | ﹤0.01% | 1935 |
|
2018
Q1 | $1.59M | Buy |
61,778
+38,198
| +162% | +$984K | ﹤0.01% | 2996 |
|
2017
Q4 | $635K | Buy |
23,580
+5,248
| +29% | +$141K | ﹤0.01% | 3406 |
|
2017
Q3 | $683K | Buy |
18,332
+5,201
| +40% | +$194K | ﹤0.01% | 3190 |
|
2017
Q2 | $326K | Buy |
+13,131
| New | +$326K | ﹤0.01% | 3567 |
|